Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen …

RP Dorin, G Lieskovsky, AS Fairey, J Cai… - … Oncology: Seminars and …, 2013 - Elsevier
Objectives To evaluate the outcomes of radical prostatectomy (RP) and pelvic lymph node
dissection (PLND) for clinically organ confined prostate cancer (CaP) with regional lymph …

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen …

RP Dorin, G Lieskovsky, AS Fairey, J Cai… - Urologic …, 2013 - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate the outcomes of radical prostatectomy (RP) and pelvic lymph node
dissection (PLND) for clinically organ confined prostate cancer (CaP) with regional lymph …

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen …

RP Dorin, G Lieskovsky, AS Fairey, J Cai… - Urologic …, 2012 - europepmc.org
Objectives To evaluate the outcomes of radical prostatectomy (RP) and pelvic lymph node
dissection (PLND) for clinically organ confined prostate cancer (CaP) with regional lymph …

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen …

RP Dorin, G Lieskovsky, AS Fairey, J Cai… - … Oncology: Seminars and …, 2013 - infona.pl
To evaluate the outcomes of radical prostatectomy (RP) and pelvic lymph node dissection
(PLND) for clinically organ confined prostate cancer (CaP) with regional lymph node …

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen …

RP Dorin, G Lieskovsky, AS Fairey, J Cai… - … Oncology: Seminars and …, 2013 - infona.pl
To evaluate the outcomes of radical prostatectomy (RP) and pelvic lymph node dissection
(PLND) for clinically organ confined prostate cancer (CaP) with regional lymph node …